InMed Pharmaceuticals Inc.INMNASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank86
Studio
Year-over-Year Change

Return on equity

Latest
-44.59%
↑ 55% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-98.98%
Historical baseline
PeriodValueYoY Change
2025-44.59%+26.9%
2024-60.96%-22.9%
2023-49.62%+68.8%
2022-159.12%-14.8%
2021-138.65%+8.8%
2020-152.07%-110.9%
2019-72.10%-121.7%
2018-32.53%+42.1%
2017-56.16%+74.9%
2016-223.94%-